Evaluation of avian paramyxovirus serotypes 2 to 10 as vaccine vectors in chickens previously immunized against Newcastle disease virus

scientific article published on 14 May 2014

Evaluation of avian paramyxovirus serotypes 2 to 10 as vaccine vectors in chickens previously immunized against Newcastle disease virus is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.VETIMM.2014.05.001
P698PubMed publication ID24880702

P2093author name stringHirokazu Hikono
Takehiko Saito
Ryota Tsunekuni
P2860cites workClassification of avian paramyxoviruses by immunodiffusion on the basis of antigenic specificity of their M protein antigens.Q45979013
Emergence of a new genetic lineage of Newcastle disease virus in West and Central Africa--implications for diagnosis and controlQ46050321
Protective effects of HN and F glycoprotein-specific monoclonal antibodies on experimental Newcastle diseaseQ47858116
Natural and experimental infection of turkeys with avian paramyxovirus-7Q57109224
Antigenic relationships between avian paramyxoviruses. I. Quantitative characteristics based on hemagglutination and neuraminidase inhibition testsQ68965252
Serological survey on prevalence of antibodies to avian paramyxovirus serotype 2 in ChinaQ80222338
Pathogenicity of PMV-3/parakeet/Netherlands/449/75 for chickensQ81927567
Recombinant herpesvirus of turkeys as a vector-based vaccine against highly pathogenic H7N1 avian influenza and Marek's diseaseQ84930135
Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses.Q30357521
Evidence for a new avian paramyxovirus serotype 10 detected in rockhopper penguins from the Falkland IslandsQ30496940
Immunization of chickens with Newcastle disease virus expressing H5 hemagglutinin protects against highly pathogenic H5N1 avian influenza virusesQ33490614
Complete genome sequence of avian paramyxovirus (APMV) serotype 5 completes the analysis of nine APMV serotypes and reveals the longest APMV genomeQ33533355
Recombinant Newcastle disease virus as a vaccine vectorQ33850246
Retracted: Replication, Neurotropism, and Pathogenicity of Avian Paramyxovirus Serotypes 1-9 in Chickens and DucksQ34256243
Evaluation of the Newcastle disease virus F and HN proteins in protective immunity by using a recombinant avian paramyxovirus type 3 vector in chickensQ35077454
Avian paramyxovirus serotypes 2-9 (APMV-2-9) vary in the ability to induce protective immunity in chickens against challenge with virulent Newcastle disease virus (APMV-1).Q35790333
Pathogenesis of Two Strains of Avian Paramyxovirus Serotype 2, Yucaipa and Bangor, in Chickens and TurkeysQ36190536
Development of nonhuman adenoviruses as vaccine vectorsQ36317264
The use of vaccination as an option for the control of avian influenzaQ36856576
A recombinant Newcastle disease virus (NDV) expressing VP2 protein of infectious bursal disease virus (IBDV) protects against NDV and IBDV.Q37492711
Detection of paramyxoviruses in Magellanic penguins (Spheniscus magellanicus) on the Brazilian tropical coast.Q39008492
A recombinant vesicular stomatitis virus replicon vaccine protects chickens from highly pathogenic avian influenza virus (H7N1).Q39897024
Generation of a recombinant chimeric Newcastle disease virus vaccine that allows serological differentiation between vaccinated and infected animalsQ40828974
Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidaseQ41441113
Complete genome sequence of a novel avian paramyxovirusQ41904651
Antigenic and genetic analyses of isolate APMV/wigeon/Italy/3920-1/2005 indicate that it represents a new avian paramyxovirus (APMV-12).Q44166693
Effect of paramyxovirus yucaipa on fertility, hatchability, and poult yield of turkeys.Q44789204
Prevalence of antibodies to different avian paramyxoviruses in commercial poultry in the United StatesQ45163873
Detection and isolation of exotic Newcastle disease virus from field-collected fliesQ45399834
Protection of chickens against highly lethal H5N1 and H7N1 avian influenza viruses with a recombinant fowlpox virus co-expressing H5 haemagglutinin and N1 neuraminidase genesQ45723618
Protection of chickens against very virulent infectious bursal disease virus (IBDV) and Marek's disease virus (MDV) with a recombinant MDV expressing IBDV VP2.Q45749425
Evaluation of Different Methods of Inactivation of Newcastle Disease Virus and Avian Influenza Virus in Egg Fluids and SerumQ45856223
P433issue3-4
P921main subjectNewcastle disease virusQ327082
immunizationQ1415366
vector-borne diseaseQ2083837
Newcastle diseaseQ11903425
P304page(s)184-191
P577publication date2014-05-14
P1433published inVeterinary Immunology and ImmunopathologyQ7923704
P1476titleEvaluation of avian paramyxovirus serotypes 2 to 10 as vaccine vectors in chickens previously immunized against Newcastle disease virus
P478volume160

Reverse relations

cites work (P2860)
Q40362937A novel chimeric Newcastle disease virus vectored vaccine against highly pathogenic avian influenza virus
Q58800131Diagnostic and Vaccination Approaches for Newcastle Disease Virus in Poultry: The Current and Emerging Perspectives
Q91258218Improvement of a recombinant avian avulavirus serotype 10 vectored vaccine by the addition of untranslated regions
Q47604109Next-generation sequencing of five new avian paramyxoviruses 8 isolates from Kazakhstan indicates a low genetic evolution rate over four decades.

Search more.